MONTIVIB AL MONTELUKAST SODIUM 10mg. IP + AMBROXOL 75mg. IP + LEVOCETIRIZINE 5mg. IP

Montivib AL tablets from Vibcare Pharma combine Montelukast, Ambroxol and Levocetirizine for allergy symptoms, asthma care and cough with mucus. Main uses: relief of symptoms of seasonal allergic rhinitis such as sneezing, runny nose, itchy nose and watery eyes, only in patients who do not respond to or cannot take alternative therapies, as serious mood and behaviour changes have been reported; relief of symptoms of perennial allergic rhinitis, only in patients who do not respond to or cannot take alternative therapies, as serious mood and behaviour changes have been reported; prophylaxis and long-term treatment of asthma; productive cough with thick, sticky mucus in acute or chronic bronchitis; uncomplicated skin symptoms of chronic idiopathic urticaria such as itching and hives.

Common side effects of Montivib AL Tablet include drowsiness or somnolence; headache; dry mouth; fatigue or weakness; abdominal pain; diarrhoea. Get medical help at once if you notice mood or behaviour changes such as agitation, aggression, depression, sleep disturbance or suicidal thoughts; urinary retention; severe allergic reactions including swelling of the face or lips and anaphylaxis.

Each Montivib AL tablet contains Montelukast Sodium 10 mg + Ambroxol 75 mg + Levocetirizine 5 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Montivib AL Tablet only as your doctor advises.

The MRP of Montivib AL Tablet is ₹169 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹128.76 and the PTS is ₹115.89.

Each Montivib AL tablet contains Montelukast Sodium 10 mg + Ambroxol 75 mg + Levocetirizine 5 mg. It comes in a pack of 10x10 (Alu Alu).

Montelukast Sodium blocks the action of leukotrienes in the airways, so there is less swelling and tightening there. Ambroxol thins thick, sticky mucus and helps it move out of the bronchial tubes. Levocetirizine acts on histamine H1 receptors and brings down sneezing, runny nose, itching and watery eyes linked to allergy.

Must not be used by anyone with a known allergy to any of these ingredients or to cetirizine. Must not be used to treat a sudden or acute asthma attack. Must not be used in end-stage kidney disease or in patients on dialysis. Avoid driving and other hazardous activities that need full alertness when this medicine affects you, and avoid alcohol and other medicines that cause drowsiness. Aspirin-sensitive patients must continue to avoid aspirin and similar painkillers. Check with a doctor first if you have kidney or liver disease, are pregnant or breastfeeding, or have a spinal cord lesion or prostate enlargement that can block urine.

Montivib AL Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.